The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.

[1]  E. Sturgis,et al.  Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Aiping Zhang,et al.  Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues , 2018, BioMed research international.

[3]  S. Chiocca,et al.  Human Papilloma Virus and Autophagy , 2018, International journal of molecular sciences.

[4]  J. Townsend,et al.  CDKN2A copy number loss in HPV- and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. , 2017 .

[5]  O. T. Selcuk.  Human papillomavirus positive oropharyngeal cancer: The general information , 2016 .

[6]  E. King,et al.  Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors , 2016, Oncotarget.

[7]  S. Kjaer,et al.  TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions. , 2016, American journal of cancer research.

[8]  R. Burkhardt,et al.  MicroRNAs as Salivary Markers for Periodontal Diseases: A New Diagnostic Approach? , 2016, BioMed research international.

[9]  M. B. Gillespie,et al.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients , 2016, Head & neck.

[10]  M. Scholz,et al.  The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer , 2015, International Journal of Cancer.

[11]  L. Schumaker,et al.  Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer. , 2015, Oral oncology.

[12]  T. Day,et al.  Oral cavity and oropharyngeal squamous cell carcinoma—an update , 2015, CA: a cancer journal for clinicians.

[13]  J. Gornbein,et al.  HPV-Positive Oropharyngeal Carcinoma , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  C. Belka,et al.  Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients , 2015, British Journal of Cancer.

[15]  Liang Zhao,et al.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses , 2015, Molecular Cancer.

[16]  Kevin P. White,et al.  Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes , 2014, Clinical Cancer Research.

[17]  S. Chiocca,et al.  HPV in oropharyngeal cancer: the basics to know in clinical practice , 2014, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[18]  L. Konge,et al.  Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review , 2014, British Journal of Cancer.

[19]  S. Willems,et al.  Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma , 2014, Epigenetics.

[20]  E. Sturgis,et al.  Differences in Imaging Characteristics of HPV-Positive and HPV-Negative Oropharyngeal Cancers: A Blinded Matched-Pair Analysis , 2013, American Journal of Neuroradiology.

[21]  L. Waldron,et al.  Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma , 2013, Clinical Cancer Research.

[22]  Christopher R. Cabanski,et al.  Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes , 2013, PloS one.

[23]  Xiaowei Wang,et al.  Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx , 2012, Modern Pathology.

[24]  Xiaowei Wang,et al.  A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma , 2013, Cancer.

[25]  Mengyao Tan,et al.  The Human Papillomavirus E6 Oncogene Represses a Cell Adhesion Pathway and Disrupts Focal Adhesion through Degradation of TAp63β upon Transformation , 2011, PLoS pathogens.

[26]  J. Paramio,et al.  Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling , 2009, Current genomics.

[27]  L. Zhao,et al.  Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. , 2009, Archives of otolaryngology--head & neck surgery.

[28]  R. Ferris,et al.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. , 2007, European journal of cancer.

[29]  A. Klingelhutz,et al.  Human Papillomavirus Type 16 E6 Activates NF-κB, Induces cIAP-2 Expression, and Protects against Apoptosis in a PDZ Binding Motif-Dependent Manner , 2006, Journal of Virology.

[30]  Y. Loo,et al.  Recruitment of Replication Protein A by the Papillomavirus E1 Protein and Modulation by Single-Stranded DNA , 2004, Journal of Virology.

[31]  H. Meir,et al.  A clinical review , 2003 .

[32]  M. Lisanti,et al.  Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. , 2001, Molecular biology of the cell.

[33]  M. Lisanti,et al.  Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. , 2000, Biochemistry.

[34]  D. Schadendorf,et al.  Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter. , 1995, Cancer research.

[35]  A. Debant,et al.  The LAR transmembrane protein tyrosine phosphatase and a coiled‐coil LAR‐interacting protein co‐localize at focal adhesions. , 1995, The EMBO journal.